159 related articles for article (PubMed ID: 839566)
21. Tumor x host cell hybrids in the mouse: chromosomes from the normal cell parent maintained in malignant hybrid tumors.
Avilès D; Jami J; Rousset JP; Ritz E
J Natl Cancer Inst; 1977 May; 58(5):1391-9. PubMed ID: 853528
[TBL] [Abstract][Full Text] [Related]
22. Chromosomes in tumors derived from mouse tumor x diploid cell hybrids obtained in vitro.
Avilès D; Ritz E; Jami J
Somatic Cell Genet; 1980 Mar; 6(2):171-86. PubMed ID: 6967231
[TBL] [Abstract][Full Text] [Related]
23. Expression of malignancy in interspecies Chinese hamster X mouse cell hybrids.
Barski G; Blanchard MG; Youn JK; Leon B
J Natl Cancer Inst; 1973 Sep; 51(3):781-92. PubMed ID: 4355218
[No Abstract] [Full Text] [Related]
24. Suppressor genes for malignant and anchorage-independent phenotypes located on human chromosome 9 have no dosage effects.
Islam MQ; Islam K
Cytogenet Cell Genet; 2000; 88(1-2):103-9. PubMed ID: 10773681
[TBL] [Abstract][Full Text] [Related]
25. Multiple human chromosomes carrying tumor-suppressor functions for the mouse melanoma cell line B16-F10, identified by microcell-mediated chromosome transfer.
Kugoh H; Nakamoto H; Inoue J; Funaki K; Barrett JC; Oshimura M
Mol Carcinog; 2002 Nov; 35(3):148-56. PubMed ID: 12410566
[TBL] [Abstract][Full Text] [Related]
26. Suggestive evidence for functionally distinct, tumor-suppressor genes on chromosomes 1 and 11 for a human fibrosarcoma cell line, HT1080.
Kugoh HM; Hashiba H; Shimizu M; Oshimura M
Oncogene; 1990 Nov; 5(11):1637-44. PubMed ID: 2267132
[TBL] [Abstract][Full Text] [Related]
27. Suppression of tumorigenicity, but not invasion, in glioblastoma/HeLa cell hybrids.
Ess K; Chen H; Kier A; Brackenbury R
J Cell Physiol; 1995 Mar; 162(3):341-7. PubMed ID: 7860642
[TBL] [Abstract][Full Text] [Related]
28. Relationship between tumorigenicity and the dosage of lymphoma- vs. normal-parent-derived chromosome 15 in somatic cell hybrids between lymphoma cells with rearranged pvt-1 gene and normal cells.
Uno M; Wirschubsky Z; Wiener F; Klein G
Int J Cancer; 1989 Aug; 44(2):353-9. PubMed ID: 2788146
[TBL] [Abstract][Full Text] [Related]
29. Correlation of the inability to sustain growth in defined serum-free medium with the suppression of tumorigenicity in Wilms' nephroblastoma.
Dowdy SF; Weissman BE; Stanbridge EJ
J Cell Physiol; 1991 May; 147(2):248-55. PubMed ID: 1645741
[TBL] [Abstract][Full Text] [Related]
30. Selective suppression of metastasis but not tumorigenicity of a mouse lung carcinoma by cell hybridization.
Layton MG; Franks LM
Int J Cancer; 1986 May; 37(5):723-30. PubMed ID: 3699933
[TBL] [Abstract][Full Text] [Related]
31. Tumorigenicity, major histocompatibility antigens, and karyotypes of interspecific hybrids between mouse neuroblastoma and rat glioma or liver cells.
Higashida H; Kano-Tanaka K; Tanaka T; Fukami H; Natsume-Sakai S
Cancer Genet Cytogenet; 1985 Apr; 16(3):219-27. PubMed ID: 3978591
[TBL] [Abstract][Full Text] [Related]
32. Expression of transformation markers and suppression of tumorigenicity in human cell hybrids.
Larizza L; Tenchini ML; Mottura A; De Carli L; Colombi M; Barlati S
Eur J Cancer Clin Oncol; 1982 Sep; 18(9):845-51. PubMed ID: 6961038
[TBL] [Abstract][Full Text] [Related]
33. Immune response to somatic cell hybrids between ultraviolet radiation-induced regressor and spontaneous progressor C3H mouse tumor cells.
Chen PW; Kaba DS; Ananthaswamy HN
Cancer Res; 1990 Mar; 50(5):1544-9. PubMed ID: 2137370
[TBL] [Abstract][Full Text] [Related]
34. Somatic cell hybrids between totipotent mouse teratocarcinoma and rat hepatoma cells.
Litwack G; Croce CM
J Cell Physiol; 1979 Oct; 101(1):1-8. PubMed ID: 44296
[TBL] [Abstract][Full Text] [Related]
35. Predominance of the metastatic phenotype in somatic cell hybrids of the K-1735 murine melanoma.
Staroselsky AH; Pathak S; Chernajovsky Y; Tucker SL; Fidler IJ
Cancer Res; 1991 Dec; 51(23 Pt 1):6292-8. PubMed ID: 1834329
[TBL] [Abstract][Full Text] [Related]
36. Antigen expression by somatic cell hybrids of a murine embryonal carcinoma cell with thymocytes and L cells.
Andrews PW; Goodfellow PN
Somatic Cell Genet; 1980 Mar; 6(2):271-84. PubMed ID: 6994266
[TBL] [Abstract][Full Text] [Related]
37. Altered differentiation, indefinite growth potential, diminished tumorigenicity, and suppressed chimerization potential of hybrids between mouse teratocarcinoma cells and thymocytes.
Martin GM; Ogburn CE; Au K; Disteche CM
J Exp Pathol; 1984; 1(2):103-33. PubMed ID: 6599936
[TBL] [Abstract][Full Text] [Related]
38. Suppression of tumorigenicity in somatic cell hybrids. IV. Chromosomes of normal human cells associated with suppression of tumorigenicity in hybrids with D98AH2 carcinoma cells.
Klinger HP; Kaelbling M
Cytogenet Cell Genet; 1986; 42(4):225-35. PubMed ID: 3463446
[TBL] [Abstract][Full Text] [Related]
39. Tumorigenicity and intracisternal A-particle expression of hybrids between murine myeloma and lymphocytes.
Giacomoni D
Cancer Res; 1979 Nov; 39(11):4481-4. PubMed ID: 498079
[TBL] [Abstract][Full Text] [Related]
40. Markers of neoplastic transformation in epithelial cell lines derived from human carcinomas.
Marshall CJ; Franks LM; Carbonell AW
J Natl Cancer Inst; 1977 Jun; 58(6):1743-51. PubMed ID: 864752
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
